Prime Medicine (NASDAQ:PRME) Shares Up 8.4% – Still a Buy?
by Teresa Graham · The Cerbat GemPrime Medicine, Inc. (NASDAQ:PRME – Get Free Report) traded up 8.4% on Wednesday . The company traded as high as $4.52 and last traded at $4.51. 1,555,082 shares changed hands during trading, a decline of 51% from the average session volume of 3,151,651 shares. The stock had previously closed at $4.16.
Wall Street Analyst Weigh In
PRME has been the topic of several analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Prime Medicine in a report on Monday, December 29th. Wall Street Zen lowered shares of Prime Medicine from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Finally, Lifesci Capital upgraded shares of Prime Medicine to a “strong-buy” rating in a report on Tuesday, December 23rd. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Prime Medicine has a consensus rating of “Moderate Buy”.
View Our Latest Stock Report on PRME
Prime Medicine Stock Performance
The company’s 50-day moving average price is $3.76.
Prime Medicine (NASDAQ:PRME – Get Free Report) last posted its quarterly earnings data on Friday, November 7th. The company reported ($0.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.04). Prime Medicine had a negative return on equity of 163.51% and a negative net margin of 3,301.64%.The company had revenue of $1.23 million for the quarter.
Prime Medicine Company Profile
We are a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying our Prime Editing technology, which we believe is a versatile, precise, efficient and broad gene editing technology. Genetic mutations implicated in disease are diverse and can range from errors of a single base, known as point mutations, to errors that extend beyond a single base, such as insertions, deletions, duplications, or combinations thereof.